Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

Little information exists regarding Ebola vaccine rVSVΔG-ZEBOV-GP and pregnancy. The Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE) randomized participants without blinding to immediate or deferred (18–24 weeks postenrollment) vaccination. Pregnancy was an exclusion criterion, but...

Full description

Bibliographic Details
Main Authors: Jennifer K. Legardy-Williams, Rosalind J. Carter, Susan T. Goldstein, Olamide D. Jarrett, Elena Szefer, Augustin E. Fombah, Sarah C. Tinker, Mohamed Samai, Barbara E. Mahon
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-03-01
Series:Emerging Infectious Diseases
Subjects:
Ebola
pregnancy
Ebola virus disease
vaccine safety
Ebola vaccine
viruses
Online Access:https://wwwnc.cdc.gov/eid/article/26/3/19-1018_article

Internet

https://wwwnc.cdc.gov/eid/article/26/3/19-1018_article

Similar Items